GSK Sells Rights to Drug Candidate to Alfasigma for Up to $690 Million

13 hours ago 1
Under the deal, Alfasigma volition summation rights to develop, manufacture and commercialize linerixibat.
Read Entire Article
  1. Homepage
  2. Health
  3. GSK Sells Rights to Drug Candidate to Alfasigma for Up to $690 Million

Related

Wegovy maker Novo Nordisk said it is teaming up with Hims & Hers Health to sell its weight-loss drugs through the telehealth company’s platform

Wegovy maker Novo Nordisk said it is teaming up with Hims & ...

3 hours ago 1
Roche Breast-Cancer Treatment Falls Short of Primary Goal in Late-Stage Study

Roche Breast-Cancer Treatment Falls Short of Primary Goal in...

15 hours ago 5
Sent 90 miles after giving birth while 'soaked in urine'

Sent 90 miles after giving birth while 'soaked in urine'

20 hours ago 1

Popular

Formula One comes to Apple TV: Everything you need to know about the new F1 2026 season

Formula One comes to Apple TV: Everything you need to know a...

3 days ago 24
Meta to Create New Applied AI Engineering Organization

Meta to Create New Applied AI Engineering Organization

6 days ago 21
Former Barclays Center Executive Says Live Nation Threatened to Pull Tours

Former Barclays Center Executive Says Live Nation Threatened...

4 days ago 20
Colorado Governor Signals He’ll Commute Sentence of Election Denier

Colorado Governor Signals He’ll Commute Sentence of Election...

4 days ago 18
Is He the Last Man in Naples, Italy, to Paint Numbers By Hand?

Is He the Last Man in Naples, Italy, to Paint Numbers By Han...

6 days ago 16
About Us · Contact Us · Privacy Policy ·

© DISQUS CLUB 2026. All rights are reserved